tiprankstipranks
Avalon GloboCare (ALBT)
NASDAQ:ALBT
US Market

Avalon GloboCare (ALBT) Price & Analysis

Compare
314 Followers

ALBT Stock Chart & Stats


---

Financials

Quarterly

Ownership Overview

0.38%0.99%98.42%
Insiders
0.99% Other Institutional Investors
98.42% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

ALBT FAQ

What was Avalon GloboCare’s price range in the past 12 months?
Avalon GloboCare lowest stock price was $2.11 and its highest was $21.60 in the past 12 months.
    What is Avalon GloboCare’s market cap?
    Avalon GloboCare’s market cap is $6.88M.
      When is Avalon GloboCare’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Avalon GloboCare’s earnings last quarter?
      Avalon GloboCare released its earnings results on May 11, 2018. The company reported -$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.021.
        Is Avalon GloboCare overvalued?
        According to Wall Street analysts Avalon GloboCare’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Avalon GloboCare pay dividends?
          Avalon GloboCare does not currently pay dividends.
          What is Avalon GloboCare’s EPS estimate?
          Avalon GloboCare’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Avalon GloboCare have?
          Avalon GloboCare has 1,094,221 shares outstanding.
            What happened to Avalon GloboCare’s price movement after its last earnings report?
            Avalon GloboCare reported an EPS of -$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Avalon GloboCare?
              Currently, no hedge funds are holding shares in ALBT
              ---

              Company Description

              Avalon GloboCare

              Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and provision of healthcare services. It operates through the following segments: Real Property Operating; Medical Related Consulting Services; and Development Services and Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cerus
              Veru
              Atossa Therapeutics
              Sorrento Therapeutics
              ADMA Biologics
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis